Alternative sources of adult stem cells: Human amniotic membrane

Advances in Biochemical Engineering/Biotechnology

Volumn 123, Issue , 2010, Pages 1-27

  Wolbank, Susanne ^a,b   van Griensven, Martijn ^a,b   Grillari Voglauer, Regina ^d   Peterbauer Scherb, Anja ^c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Austrian Cluster for Tissue Regeneration   (Austria)

^c Red Cross Blood Transfusion Service of Upper Austria   (Austria)

^d UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

Adipogenesis; Expansion; hTERT; Human amniotic cells; Immortalization; Immunomodulation; Immunophenotype; Mesenchymal markers; Osteogenesis; Platelet lysate; Stem cell markers; Telomerase

Indexed keywords

ADULT STEM CELL; AMNION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; METHODOLOGY; PHYSIOLOGY; TISSUE ENGINEERING;

ADULT STEM CELLS; AMNION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; HUMANS; TISSUE ENGINEERING;

ANIMALIA;

EID: 78650636833     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2010_71     Document Type: Article

References (85)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147
2. Rubio D, Garcia-Castro J, Martin MC et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039
3. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
4. D'Ippolito G, Schiller PC, Ricordi C et al (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14:1115-1122
5. Arai F, Ohneda O, Miyamoto T et al (2002) Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195:1549-1563
6. De Bari C, Dell'Accio F, Tylzanowski P et al (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928-1942
7. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242
8. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338-1345
9. Young HE, Steele TA, Bray RA et al (2001) Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264:51-62
10. Zuk PA, Zhu M, Mizuno H et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228
11. Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al (2000) Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2:477-488
12. Erbs S, Linke A, Schächinger V et al (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 116:366-374
13. García-Olmo D, García-Arranz M, Herreros D et al (2005) A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416-1423
14. Horwitz EM, Gordon PL, Koo WK et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937
15. Mazzini L, Mareschi K, Ferrero I et al (2006) Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 28:523-526
16. Mohyeddin Bonab M, Yazdanbakhsh S, Lotfi J et al (2007) Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 4:50-57
17. Ringdén O, Uzunel M, Rasmusson I et al (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397
18. Miki T, Lehmann T, Cai H et al (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549-1559
19. Parolini O, Alviano F, Bagnara GP et al (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 26:300-311
20. Casey ML, MacDonald PC (1996) Interstitial collagen synthesis and processing in human amnion: a property of the mesenchymal cells. Biol Reprod 55:1253-1260
21. Sakuragawa N, Tohyama J, Yamamoto H (1995) Immunostaining of human amniotic epithelial cells: possible use as a transgene carrier in gene therapy for inborn errors of metabolism. Cell Transplant 4:343-346
22. Ilancheran S, Michalska A, Peh G et al (2007) Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77:577-588
23. Portmann-Lanz CB, Schoeberlein A, Huber A et al (2006) Placental mesenchymal stem cells as potential autologous graft for pre-and perinatal neuroregeneration. Am J Obstet Gynecol 194:664-673
24. Wolbank S, Peterbauer A, Fahrner M et al (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183
25. Zhao P, Ise H, Hongo M et al (2005) Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79:528-535
26. Bailo M, Soncini M, Vertua E et al (2004) Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78:1439-1448
27. Kubo M, Sonoda Y, Muramatsu R et al (2001) Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 42:1539-1546
28. Gajiwala K, Gajiwala AL (2004) Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank 5:73-80
29. Tosi GM, Traversi C, Schuerfeld K et al (2005) Amniotic membrane graft: histopathological findings in five cases. J Cell Physiol 202:852-857
30. Boquest AC, Shahdadfar A, Frønsdal K et al (2005) Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16:1131-1141
31. Mitchell JB, McIntosh K, Zvonic S et al (2006) Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376-385
32. Yoshimura K, Shigeura T, Matsumoto D et al (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208:64-76
33. Doucet C, Ernou I, Zhang Y et al (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228-236
34. McIntosh KR, Lopez MJ, Borneman JN et al (2009) Immunogenicity of allogeneic adiposederived stem cells in a rat spinal fusion model. Tissue Eng Part A (Epub ahead of print)
35. Selvaggi TA, Walker RE, Fleisher TA (1997) Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776-779
36. Häusl P (2008) Rinderserum wird Mangelware. Transkript 14:48
37. van den Dolder J, Mooren R, Vloon AP et al (2006) Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 12:3067-3073
38. Bernardo ME, Avanzini MA, Perotti C et al (2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211:121-130
39. Bieback K, Hecker A, Kocaömer A et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells (Epub ahead of print)
40. Capelli C, Domenghini M, Borleri G et al (2007) Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 40:785-791
41. Carrancio S, López-Holgado N, Sánchez-Guijo FM et al (2008) Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36:1014-1021
42. Lange C, Cakiroglu F, Spiess AN et al (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18-26
43. Mirabet V, Solves P, Miñana MD et al (2008) Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 9:1-10
44. Müller I, Kordowich S, Holzwarth C et al (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8:437-444
45. Pérez-Ilzarbe M, Díez-Campelo M, Aranda P et al (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion (Epub ahead of print)
46. Schallmoser K, Bartmann C, Rohde E et al (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436-1446
47. Schallmoser K, Rohde E, Reinisch A et al (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14:185-196
48. Reinisch A, Bartmann C, Rohde E et al (2007) Humanized system to propagate cord bloodderived multipotent mesenchymal stromal cells for clinical application. Regen Med 2:371-382
49. Kocaoemer A, Kern S, Klüter H et al (2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270-1278
50. de Mos M, van der Windt AE, Jahr H et al (2008) Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 36:1171-1178
51. Johansson L, Klinth J, Holmqvist O et al (2003) Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology 42:67-74
52. Choi YC, Morris GM, Sokoloff L (1980) Effect of platelet lysate on growth and sulfated glycosaminoglycan synthesis in articular chondrocyte cultures. Arthritis Rheum 23:220-224
53. Drengk A, Zapf A, Stürmer EK et al (2009) Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189:317-326
54. Kaps C, Loch A, Haisch A et al (2002) Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput 40:485-490
55. Mishra A, Tummala P, King A et al (2009) Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods (Epub ahead of print)
56. Krämer DK, Bouzakri K, Holmqvist O et al (2005) Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle. Cytotechnology 48:89-95
57. Slapnicka J, Fassmann A, Strasak L et al (2008) Effects of activated and nonactivated plateletrich plasma on proliferation of human osteoblasts in vitro. J Oral Maxillofac Surg 66:297-301
58. Umeno Y, Okuda A, Kimura G (1989) Proliferative behaviour of fibroblasts in plasma-rich culture medium. J Cell Sci 94:567-575
59. Krasna M, Domanović D, Tomsic A et al (2007) Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat 16:105-110
60. Pepelassi EA, Markopoulou CE, Dereka XE et al (2009) Platelet-rich plasma effect on periodontally affected human gingival fibroblasts: an in vitro study. J Int Acad Periodontol 11:160-168
61. Davenport M, Verrier S, Droeser R et al (2009) Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 15:869-875
62. Kitoh H, Kitakoji T, Tsuchiya H et al (2007) Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of cultureexpanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop 27:629-634
63. Lataillade JJ, Doucet C, Bey E et al (2007) New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2:785-794
64. Wall ME, Bernacki SH, Loboa EG (2007) Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng 13:1291-1298
65. Bodnar AG, Ouellette M, Frolkis M et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352
66. Chang MW, Grillari J, Mayrhofer C et al (2005) Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp Cell Res 309:121-136
67. Wieser M, Stadler G, Jennings P et al (2008) hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 295:F1365-F1375
68. Stadler G, Hennerbichler S, Lindenmair A et al (2008) Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy 10:743-752
69. Stadler G, Wieser M, Streubel B et al (2008) Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma. Eur J Cancer 44:866-875
70. Voglauer R, Grillari J, Fortschegger K et al (2005) Establishment of human fibroma cell lines from a MEN1 patient by introduction of either hTERT or SV40 early region. Int J Oncol 26:961-970
71. Abdallah BM, Haack-Sørensen M, Burns JS et al (2005) Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite extensive proliferation. Biochem Biophys Res Commun 326:527-538
72. Simonsen JL, Rosada C, Serakinci N et al (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592-596
73. Jun ES, Lee TH, Cho HH et al (2004) Expression of telomerase extends longevity and enhances differentiation in human adipose tissue-derived stromal cells. Cell Physiol Biochem 14:261-268
74. Shi S, Gronthos S, Chen S et al (2002) Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 20:587-591
75. Wolbank S, Stadler G, Peterbauer A et al (2009) Telomerase immortalized human amnionand adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. Tissue Eng Part A 15:1843-1854
76. Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367
77. Le Blanc K, Tammik L, Sundberg B et al (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20
78. Le Blanc K, Tammik C, Rosendahl K et al (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896
79. McIntosh K, Zvonic S, Garrett S et al (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246-1253
80. Puissant B, Barreau C, Bourin P et al (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118-129
81. Rasmusson I, Ringdén O, Sundberg B (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305:33-41
82. Lee JM, Dedhar S, Kalluri R et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973-981
83. Campioni D, Lanza F, Moretti S et al (2008) Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy 10:69-82
84. Zhang X, Soda Y, Takahashi K et al (2006) Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochem Biophys Res Commun 351:853-859
85. Burns JS, Abdallah BM, Guldberg P et al (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135